Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece
Sign Up to like & getrecommendations! Published in 2019 at "Hormones"
DOI: 10.1007/s42000-019-00153-1
Abstract: To assess the efficacy of a real-time continuous glucose monitoring (RT–CGM) system added to insulin pump therapy for 3 months, in sub-optimally controlled adults with type 1 diabetes mellitus (T1D). This was a prospective, multicenter,… read more here.
Keywords: real time; time continuous; cgm system; study ... See more keywords
Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT‐CGM system in Germany, Sweden and the United Kingdom (2018–2020)
Sign Up to like & getrecommendations! Published in 2022 at "Diabetic Medicine"
DOI: 10.1111/dme.14946
Abstract: Regional variations in the adoption of diabetes technology may be reflected in population‐level metrics of glycaemic control. In this observational study, we aimed to assess the glycaemic impacts of transitioning from the Dexcom G5 Real‐Time… read more here.
Keywords: longitudinal analysis; transitioning dexcom; analysis users; cgm system ... See more keywords
Development of Smartphone-Controlled and Microneedle-Based Wearable Continuous Glucose Monitoring System for Home-Care Diabetes Management.
Sign Up to like & getrecommendations! Published in 2023 at "ACS sensors"
DOI: 10.2139/ssrn.4281506
Abstract: Continuous glucose monitoring (CGM) can mini-invasively track blood glucose fluctuation and reduce the risk of hyperglycemia and hypoglycemia, and this is is in great demand for diabetes management. However, cost-effective manufacture of CGM systems with… read more here.
Keywords: system; cgm; cgm system; glucose monitoring ... See more keywords
First Assessment of the Performance of an Implantable CGM System through 180 Days in a Primarily Adolescent Population with Type 1 Diabetes
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-13-or
Abstract: Background: An implantable continuous glucose monitoring (CGM) system (Eversense ® XL, Senseonics, Maryland U.S.A) recently received CE Mark for 180-day duration in adults. The current study is the first investigation of the performance of the… read more here.
Keywords: primarily adolescent; system; cgm system; adolescent population ... See more keywords